X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.980
-0.020 (-0.50%)
At close: Jul 31, 2026, 4:00 PM EDT
3.970
-0.010 (-0.25%)
After-hours: Jul 31, 2026, 7:34 PM EDT
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 45 employees as of December 31, 2025. The number of employees decreased by 98 or -68.53% compared to the previous year.
Employees
45
Change (1Y)
-98
Growth (1Y)
-68.53%
Revenue / Employee
$200,311
Profits / Employee
-$2,216,044
Market Cap
375.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -98 | -68.53% |
| Dec 31, 2024 | 143 | 50 | 53.76% |
| Dec 31, 2023 | 93 | 23 | 32.86% |
| Dec 31, 2022 | 70 | -13 | -15.66% |
| Dec 31, 2021 | 83 | 11 | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| C4 Therapeutics | 104 |
| Scribe Therapeutics | 89 |
| Editas Medicine | 87 |
| Century Therapeutics | 78 |
| Larimar Therapeutics | 71 |
XFOR News
- 21 days ago - X4 Pharmaceuticals initiated with an Overweight at Wells Fargo - TheFly
- 24 days ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - X4 Pharmaceuticals appoints CAMP4 Therapeutics CFO Kelly Gold to board - TheFly
- 4 weeks ago - X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - X4 Pharmaceuticals initiated with an Outperform at Leerink - TheFly
- 2 months ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire